Cultured AFB Antitubercular DST Rapid 15 Drugs Panel Test
Comprehensive Tuberculosis Drug Sensitivity Testing
The Cultured AFB Antitubercular DST Rapid 15 Drugs Panel Test represents a breakthrough in tuberculosis management, providing healthcare providers with critical information about drug susceptibility patterns in Mycobacterium tuberculosis complex infections. This advanced diagnostic tool is essential for combating the growing challenge of drug-resistant tuberculosis strains that threaten public health worldwide.
What This Test Measures and Detects
This sophisticated panel test evaluates the sensitivity of Mycobacterium tuberculosis complex to 15 different anti-tuberculosis medications using automated fluorescent technology. The test specifically measures:
- First-line drug sensitivity including Isoniazid, Rifampicin, Pyrazinamide, Ethambutol, and Streptomycin
- Second-line drug responses including Fluoroquinolones (Ofloxacin, Levofloxacin, Moxifloxacin)
- Aminoglycoside sensitivity (Amikacin, Kanamycin, Capreomycin)
- Other anti-TB agents including Ethionamide, Clofazimine, PAS, and Cycloserine
Who Should Consider This Test
This comprehensive drug sensitivity panel is recommended for patients experiencing:
- Persistent tuberculosis symptoms despite ongoing treatment
- Treatment failure or relapse after completing standard TB therapy
- Exposure to drug-resistant tuberculosis cases
- Immune-compromised conditions increasing TB susceptibility
- Previous history of incomplete TB treatment courses
- Suspected multi-drug resistant (MDR-TB) or extensively drug-resistant (XDR-TB) tuberculosis
Key Benefits of the 15-Drug Panel Test
Choosing this comprehensive drug sensitivity testing provides numerous advantages:
- Personalized Treatment Planning: Enables physicians to select the most effective anti-TB medications based on individual bacterial sensitivity
- Rapid Results: Provides comprehensive drug susceptibility data within 21 days using advanced automated fluorescent technology
- Cost-Effective Care: Helps avoid ineffective treatments and reduces overall healthcare costs by targeting therapy appropriately
- Public Health Protection: Identifies drug-resistant strains early to prevent community transmission
- Improved Outcomes: Significantly increases treatment success rates by ensuring appropriate medication selection
Understanding Your Test Results
Your test report will provide detailed information about how the Mycobacterium tuberculosis complex responds to each of the 15 anti-tuberculosis drugs:
- Sensitive: The bacteria are effectively killed by the medication at standard concentrations
- Resistant: The bacteria continue to grow despite the presence of the drug
- Intermediate: The bacteria show reduced sensitivity requiring higher drug concentrations
Your physician will use these results to design a customized treatment regimen that targets your specific TB strain with the most effective medications, potentially combining multiple drugs for optimal results.
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $550 |
| Regular Price | $750 |
Nationwide Testing Availability
We have diagnostic branches conveniently located across the United States, serving major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our state-of-the-art facilities ensure consistent, reliable testing results nationwide.
Take Control of Your Tuberculosis Treatment
Don’t let drug-resistant tuberculosis compromise your health. Our Cultured AFB Antitubercular DST Rapid 15 Drugs Panel Test provides the comprehensive information needed to develop an effective, personalized treatment strategy. With results available in just 21 days and samples accepted daily until 3:30 PM, getting the right treatment guidance has never been more accessible.
Ready to get started? Book your test today by calling our dedicated healthcare line at +1(267) 388-9828 or schedule your appointment online. Our team is ready to assist you with comprehensive tuberculosis drug sensitivity testing and personalized treatment guidance.
